Clinical Trial Update: A Study to Evaluate the Safety of Rosuvastatin in Children and Adolescents With Homozygous Familial Hypercholesterolemia [Phase 3]

View source ↗

Summary

A Phase 3 study evaluating the safety of rosuvastatin in children and adolescents with homozygous familial hypercholesterolemia. The trial is completed and resu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Homozygous Familial Hypercholesterolemia

Drugs mentioned

• Rosuvastatin (rosuvastatin)

Snippet

Sponsor: AstraZeneca | Conditions: Homozygous Familial Hypercholesterolemia (HoFH) | Phase 3 | Status: COMPLETED | Results posted: 2018-02-27